Results 171 to 180 of about 5,685 (219)
Some of the next articles are maybe not open access.
American Heart Journal, 1999
The primary cause of acute coronary syndromes is the development of a thrombus, a pathologic manifestation of platelet aggregation that occurs as part of the normal process of hemostasis. The discovery that the final common step in platelet aggregation, through the binding of fibrinogen to the activated platelet integrin glycoprotein (GP) IIb/IIIa, has
openaire +2 more sources
The primary cause of acute coronary syndromes is the development of a thrombus, a pathologic manifestation of platelet aggregation that occurs as part of the normal process of hemostasis. The discovery that the final common step in platelet aggregation, through the binding of fibrinogen to the activated platelet integrin glycoprotein (GP) IIb/IIIa, has
openaire +2 more sources
JAMA Neurology
Importance The addition of direct thrombin inhibitors or glycoprotein platelet inhibitors to intravenous thrombolysis in patients undergoing endovascular thrombectomy for acute ischemic stroke may improve reperfusion rates and clinical outcomes ...
Ian Rines +15 more
semanticscholar +1 more source
Importance The addition of direct thrombin inhibitors or glycoprotein platelet inhibitors to intravenous thrombolysis in patients undergoing endovascular thrombectomy for acute ischemic stroke may improve reperfusion rates and clinical outcomes ...
Ian Rines +15 more
semanticscholar +1 more source
Journal of Stroke & Cerebrovascular Diseases, 2020
BACKGROUND Early revascularization of the extracranial internal carotid artery in acute anterior circulation ischemic stroke (ACIS) is feasible and may improve clinical outcome.
N. Osteraas +3 more
semanticscholar +1 more source
BACKGROUND Early revascularization of the extracranial internal carotid artery in acute anterior circulation ischemic stroke (ACIS) is feasible and may improve clinical outcome.
N. Osteraas +3 more
semanticscholar +1 more source
Cardiology in the Young, 2021
Acute stent thrombosis may complicate neonatal arterial duct stenting for reduced pulmonary blood flow. Thrombolytic agents recanalise the clot but may cause bleeding around the vascular sheaths and other sites. Since early thrombus is platelet mediated,
Z. Mumtaz, K. Sivakumar
semanticscholar +1 more source
Acute stent thrombosis may complicate neonatal arterial duct stenting for reduced pulmonary blood flow. Thrombolytic agents recanalise the clot but may cause bleeding around the vascular sheaths and other sites. Since early thrombus is platelet mediated,
Z. Mumtaz, K. Sivakumar
semanticscholar +1 more source
Bleeding risk and safety profile related to the use of eptifibatide: a current review
Expert Opinion on Drug Safety, 2012 INTRODUCTION: Eptifibatide is a glycoprotein IIb/IIIa inhibitor that blocks the final common pathway of platelet aggregation. Its major adverse effect is bleeding. Balancing its safety and efficacy is paramount for its appropriate usage.
Fadi Saab
exaly +1 more source
Journal of Thrombosis and Thrombolysis, 2021
Jingting Liu, Yihong Yang, Hongbo Liu
semanticscholar +1 more source
Jingting Liu, Yihong Yang, Hongbo Liu
semanticscholar +1 more source